Understanding MDS Disparities: A Conversation with Dr. Ball
In this episode, Dr. Somedeb Ball from Vanderbilt University talks about his research on myelodysplastic syndromes (MDS). The discussion centers on the disparities in MDS treatment and outcomes among different racial and sex subgroups. The study highlights the need to address these disparities to improve care, particularly for minority groups who may face unique challenges. The episode also underscores the importance of increasing awareness and participation in clinical trials to ensure new treatments are effective for all patients. This conversation aims to enhance understanding and support for MDS patients, especially those from underrepresented communities.
Mary introduces the agenda of the event and our featured speaker Dr. Somedeb Ball
Dr. Ball talks about MDS disparities and asnwers your questions
Mary Arnett
Mary joined HealthTree in 2022 as a part of HealthTree's team to help expand into all blood cancers. She now works as HealthTree's Volunteer & Community Outreach Manager, helping to engage and involve community members in HealthTree's mission. When she isn't working, she loves being the fun aunt to her 13 nieces and nephews, attending concerts, experimenting with new recipes in the kitchen, and traveling to explore new cities.
Dr. Somedeb Ball
Dr. Ball is an assistant professor in the Division of Hematology and Oncology at Vanderbilt University Medical Center. He is a clinical and translational investigator specializing in myeloid hematologic malignancies, including Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML). His research focuses on understanding the molecular pathogenesis of myeloid malignancies, evaluating prognostic implications of genomic alterations, and developing novel targeted therapies.